Neola Medical Granted Patent in the USA

Neola Medical AB has been granted a patent in the USA that strengthens the protection of the company’s innovation pipeline of medical device for continuous lung monitoring. The granted patent is for a technical method which opens opportunities for lung monitoring of more patient groups than preterm born infants, and part of a patent family related to positioning the light source inside the body when measuring gas in the lungs. The approved patent is crucial for future measurements on larger patients, such as children and adults. The patent is pending in Europe and in China.

“The approval of this patent not only solidifies our competitive position in the American market but also protects a critical aspect of our technology pipeline. This patent is a cornerstone in our strategy to innovate and deliver next-generation lung monitoring solutions for patients in intensive care, including both children and adults.”, says CEO Hanna Sjöström.

Datum 2024-08-28, kl 07:00
Källa MFN
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 100 000 sidvisningar och 15 000 unika besökare per månad. Vår discord har över 6000 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!